Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

Food and Chemical Toxicology

Volumn 36, Issue 12, 1998, Pages 1085-1094

  Wolf, B W ^a   Wheeler, K B ^a   Ataya, D G ^a   Garleb, K A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

AIDS=acquired immunodeficiency syndrome; CFU=colony forming units; GI=gastrointestinal; HDL=high density lipoprotein; HIV=human immunodeficiency virus; Human immunodeficiency virus; Lactobacillus reuteri; Safety and tolerance; spp=species

Indexed keywords

PLACEBO; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOOD SAFETY; HEALTH FOOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTOBACILLUS; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIBODY FORMATION; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL DISEASES; HIV SEROPOSITIVITY; HUMANS; INTESTINES; KIDNEY FUNCTION TESTS; LACTOBACILLUS; LIVER FUNCTION TESTS; MALE; PROBIOTICS; URINALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; LACTOBACILLUS REUTERI; MICROBIOTA;

EID: 0032442239     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(98)00090-8     Document Type: Article

References (16)

1. Alak J. I., Wolf B., Mdurvwa E. G., Pimentel-Smith G. E., Adeyemo O. Effects of Lactobacillus reuteri and L. acidophilus on intestinal resistance to Cryptosporidium parvum infection in immunodeficient C56BL/6 mice. FASEB Journal. 10:1996;A796.
2. Alak J. I. B., Wolf B. W., Mdurvwa E. G., Pimentel-Smith G. E., Adeyemo O. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome. Journal of Infectious Diseases. 175:1997;218-221.
3. Axelsson L. T., Chung T. C., Dobrogosz W. J., Lindgren S. E. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microbial Ecology in Health and Disease. 2:1989;131-136.
4. Bartlett J. G. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clinical Infectious Diseases. 18:(Suppl. 4):1994;S265-S272.
5. Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. 41, 1-19.
6. Chung T. C., Axelsson L. T., Lindgren S. E., Dobrogosz W. J. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microbial Ecology in Health and Disease. 2:1989;137-144.
7. Collins F. M., Carter P. B. Growth of Salmonella in orally infected germfree mice. Infection and Immunity. 21:1978;41-47.
8. Douglas L. M. (1911) The Bacillus of Long Life. TC & EC Jack, London.
9. Gaskins H. R. (1997) Immunological aspects of host-microbiota interactions at the intestinal epithelium. In Gastrointestinal Microbiology: Vol. 2. Gastrointestinal Microbes and Host Interactions, ed. R. I. Mackie, B. A. White and R. E. Isaacson, pp. 537-587. Chapman and Hall, New York.
10. Havenaar R. and Huis in't Veld J. H. J. (1992) Probiotics: a general review. In The Lactic Acid Bacteria, ed. B. J. B. Wood, pp. 151-170. Elsevier Applied Science, New York.
11. Larson H. E., Borriello S. P. Differences between antibiotics in the induction of antibiotic-associated enterocolitis in an animal model. Journal of Medical Microbiology. 31:1990;iv.
12. Moberg L. J., Sugiyama H. Microbial ecological basis of infant botulism as studied with germfree mice. Infection and Immunity. 25:1979;653-657.
13. Shor-Posner G., Basit A., Lu Y., Cabrejos C., Chang J., Fletcher M., Mantero-Atienza E., Baum M. K. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. American Journal of Medicine. 94:1993;515-519.
14. van der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annual Review of Microbiology. 43:1989;69-87.
15. Welage L. S., Carver P. L., Revankar S., Pierson C., Kauffman C. A. Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clinical Infectious Diseases. 21:1995;1431-1438.
16. Wolf B. W., Garleb K. A., Ataya D. G., Casas I. A. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microbial Ecology in Health and Disease. 8:1995;41-50.